DELUCCIA ROBERT J - 19 Nov 2021 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
Director, 10%+ Owner
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: Robert J. DeLuccia
Issuer symbol
ACXP
Transactions as of
19 Nov 2021
Net transactions value
+$24,672
Form type
4
Filing time
22 Nov 2021, 15:05:53 UTC
Previous filing
06 Jul 2021
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACXP Common Stock Purchase $24,672 +5,034 +0.49% $4.90 1,031,461 19 Nov 2021 Direct F1
holding ACXP Common Stock 3,847 19 Nov 2021 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reflects the average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $4.886 to $4.961 per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price.

Remarks:

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.